Sugi Predict

Sugi Predict / Compounds / SCHEMBL4493722

SCHEMBL4493722

SCHEMBL4493722

CN(C)CCCc1cccc(N/C(=C2\C(=O)Nc3cc(F)ccc32)c2cccc(CC(=O)O)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 2/20 0.38
▸ FLT3 P36888 2/20 0.36
▸ LPAR1 Q92633 1/20 0.36
▸ NR1H4 Q96RI1 3/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ PLK3 Q9H4B4 1/20 0.35
▸ HPSE Q9Y251 2/20 0.35
▸ PPARG P37231 2/20 0.35
▸ PPARD Q03181 2/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ MET P08581 7/20 0.34
▸ BACE1 P56817 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ SELL P14151 1/20 0.33
▸ SELP P16109 1/20 0.33
▸ SELE P16581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4493725 1.00 PLK1 (0.38) PLK1FLT3LPAR1NR1H4PDGFRB
SCHEMBL4488724 0.95 TAAR1 (0.37) FLT3NR1H4HPSEPPARGPPARD
SCHEMBL4488727 0.95 TAAR1 (0.37) FLT3NR1H4HPSEPPARGPPARD
SCHEMBL226902 0.94 PLK1 (0.39) PLK1FLT3NR1H4PDGFRBKIT
SCHEMBL4500851 0.94 LPAR1 (0.39) PLK1FLT3LPAR1NR1H4PDGFRB
SCHEMBL4483342 0.94 BACE1 (0.38) PLK1FLT3LPAR1NR1H4HPSE
SCHEMBL4500854 0.94 LPAR1 (0.39) PLK1FLT3LPAR1NR1H4PDGFRB
SCHEMBL226903 0.94 PLK1 (0.39) PLK1FLT3NR1H4PDGFRBKIT
SCHEMBL4483345 0.94 BACE1 (0.38) PLK1FLT3LPAR1NR1H4HPSE
SCHEMBL4496876 0.90 PLK1 (0.48) PLK1FLT3NR1H4PDGFRBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 — — US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 — — US disclosed
EP-1527046-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-04 — — EP disclosed
WO-2004009546-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-01-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR PLK1 86/4885FLT3 34/4885LPAR1 912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.